• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

2

CATEGORIES

  • 9
  • 8
  • 7
  • 2
  • 2
  • 2
  • 1

PRICE

4
4
4
31

PUBLISHED

1
5
17
31

PRODUCT TYPE

28
3

Search "Idera Pharmaceuticals Inc-Therapeutic Competitors" returned 31 results.

PRODUCT TITLE

Celldex Therapeutics, Inc. (CLDX) - Financial and Strategic SWOT Analysis Review

Celldex Therapeutics, Inc. (CLDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market - Product Thumbnail Image

A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 347 colorectal cancer drugs within the portfolio of 182 companies, from Ceased to Marketed The report extensively analyses their...

March 2011
FROM

Agenus, Inc. (AGEN) - Financial and Strategic SWOT Analysis Review

Agenus, Inc. (AGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher...

February 2015
FROM

Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014

Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014 Summary This, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014’, provides an overview of the Waldenstrom Macroglobulinemia’s therapeutic...

September 2014
FROM

Waldenstrom Macroglobulinemia - Pipeline Review, H1 2014

Waldenstrom Macroglobulinemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H1 2014’, provides an overview of the Waldenstrom Macroglobulinemia’s...

April 2014
FROM

Severe Psoriasis - Pipeline Review, H1 2014

Severe Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Severe Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This...

March 2014
FROM

Pulmonary Inflammation - Pipeline Review, H1 2014

Pulmonary Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pulmonary Inflammation - Pipeline Review, H1 2014’, provides an overview of the Pulmonary Inflammation’s therapeutic...

May 2014
FROM
Analysis of Agenus Inc Analysis of Agenus Inc - Product Thumbnail Image

Analysis of Agenus Inc

Agenus Inc. is a pharmaceutical manufacturing company that is involved in the development of a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines and adjuvants for...

April 2015
FROM

Amarillo Biosciences, Inc. (AMAR) - Financial and Strategic SWOT Analysis Review

Amarillo Biosciences, Inc. (AMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Colitis - Pipeline Review, H1 2014

Colitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Colitis - Pipeline Review, H1 2014’, provides an overview of the Colitis’s therapeutic pipeline. This report provides comprehensive...

March 2014
FROM

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic...

July 2014
FROM

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015 Summary This, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015’, provides an overview of the Graft Versus Host Disease (GVHD)’s...

March 2015
FROM

Duchenne Muscular Dystrophy - Pipeline Review, H1 2015

Duchenne Muscular Dystrophy - Pipeline Review, H1 2015 Summary This, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Duchenne Muscular Dystrophy’s therapeutic...

January 2015
FROM

Hyperlipidemia - Pipeline Review, H1 2014

Hyperlipidemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H1 2014’, provides an overview of the Hyperlipidemia’s therapeutic pipeline. This report...

April 2014
FROM

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014 Summary This, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014’, provides an overview of the Graft Versus Host Disease (GVHD)’s...

September 2014
FROM

Rheumatoid Arthritis - Pipeline Review, H1 2014

Rheumatoid Arthritis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2014’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline. This...

February 2014
FROM

Moderate Psoriasis - Pipeline Review, H1 2014

Moderate Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Moderate Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Moderate Psoriasis’s therapeutic pipeline. This...

March 2014
FROM

Systemic Lupus Erythematosus - Pipeline Review, H1 2014

Systemic Lupus Erythematosus - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2014’, provides an overview of the Systemic Lupus Erythematosus’s...

February 2014
FROM

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014’, provides an overview of the Plaque...

February 2014
FROM

Moderate Psoriasis - Pipeline Review, H2 2014

Moderate Psoriasis - Pipeline Review, H2 2014 Summary This, ‘Moderate Psoriasis - Pipeline Review, H2 2014’, provides an overview of the Moderate Psoriasis’s therapeutic pipeline. This report provides...

August 2014
FROM
Loading Indicator

Our Clients

Intel Corporation Autodesk, Inc. Hewlett-Packard Company Ahlstrom Corporation SAP SE 3M Company Samsung Group Ltd.